{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T10:06:23Z","timestamp":1744193183091},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.vaccine.2008.10.046","type":"journal-article","created":{"date-parts":[[2008,11,10]],"date-time":"2008-11-10T03:10:38Z","timestamp":1226286638000},"page":"213-222","source":"Crossref","is-referenced-by-count":28,"title":["A recombinant West Nile virus envelope protein vaccine candidate produced in Spodoptera frugiperda expresSF+ cells"],"prefix":"10.1016","volume":"27","author":[{"given":"Nathalie","family":"Bonaf\u00e9","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph A.","family":"Rininger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard G.","family":"Chubet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harald G.","family":"Foellmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stacey","family":"Fader","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John F.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra L.","family":"Bushmich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Anthony","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Ledizet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erol","family":"Fikrig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond A.","family":"Koski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.vaccine.2008.10.046_bib1","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1086\/322700","article-title":"West Nile encephalitis: an emerging disease in the United States","volume":"33","author":"Marfin","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2008.10.046_bib2","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1473-3099(02)00368-7","article-title":"West Nile virus","volume":"2","author":"Campbell","year":"2002","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2008.10.046_bib3","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1172\/JCI21623","article-title":"West Nile virus: a growing concern?","volume":"113","author":"Gould","year":"2004","journal-title":"J Clin Invest"},{"issue":"30","key":"10.1016\/j.vaccine.2008.10.046_bib4","doi-asserted-by":"crossref","first-page":"5563","DOI":"10.1016\/j.vaccine.2006.12.005","article-title":"West Nile virus: recent trends in diagnosis and vaccine development","volume":"25","author":"Dauphin","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.10.046_bib5","first-page":"221","article-title":"Equine vaccine for West Nile virus","volume":"114","author":"Ng","year":"2003","journal-title":"Dev Biol (Basel)"},{"issue":"4","key":"10.1016\/j.vaccine.2008.10.046_bib6","first-page":"251","article-title":"The anamnestic serologic response to vaccination with a canarypox virus-vectored recombinant West Nile virus (WNV) vaccine in horses previously vaccinated with an inactivated WNV vaccine","volume":"5","author":"Grosenbaugh","year":"2004","journal-title":"Vet Ther"},{"issue":"9","key":"10.1016\/j.vaccine.2008.10.046_bib7","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1128\/JVI.75.9.4040-4047.2001","article-title":"West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays","volume":"75","author":"Davis","year":"2001","journal-title":"J Virol"},{"issue":"12","key":"10.1016\/j.vaccine.2008.10.046_bib8","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1086\/523650","article-title":"A West Nile virus DNA vaccine induces neutralizing antibody in healthy adults during a phase 1 clinical trial","volume":"196","author":"Martin","year":"2007","journal-title":"J Infect Dis"},{"issue":"22","key":"10.1016\/j.vaccine.2008.10.046_bib9","doi-asserted-by":"crossref","first-page":"12497","DOI":"10.1128\/JVI.78.22.12497-12507.2004","article-title":"ChimeriVax-West Nile virus live-attenuated vaccine: preclinical evaluation of safety, immunogenicity, and efficacy","volume":"78","author":"Arroyo","year":"2004","journal-title":"J Virol"},{"issue":"17","key":"10.1016\/j.vaccine.2008.10.046_bib10","doi-asserted-by":"crossref","first-page":"6694","DOI":"10.1073\/pnas.0601932103","article-title":"A live, attenuated recombinant West Nile virus vaccine","volume":"103","author":"Monath","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.vaccine.2008.10.046_bib11","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0042-6822(03)00450-1","article-title":"Molecularly engineered live-attenuated chimeric West Nile\/dengue virus vaccines protect rhesus monkeys from West Nile virus","volume":"314","author":"Pletnev","year":"2003","journal-title":"Virology"},{"issue":"40\u201341","key":"10.1016\/j.vaccine.2008.10.046_bib12","doi-asserted-by":"crossref","first-page":"6392","DOI":"10.1016\/j.vaccine.2006.06.008","article-title":"Chimeric West Nile\/dengue virus vaccine candidate: preclinical evaluation in mice, geese and monkeys for safety and immunogenicity","volume":"24","author":"Pletnev","year":"2006","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2008.10.046_bib13","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1086\/426824","article-title":"Live measles vaccine expressing the secreted form of the West Nile virus envelope glycoprotein protects against West Nile virus encephalitis","volume":"191","author":"Despres","year":"2005","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2008.10.046_bib14","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/jgm.837","article-title":"A single immunization with a minute dose of a lentiviral vector-based vaccine is highly effective at eliciting protective humoral immunity against West Nile virus","volume":"8","author":"Iglesias","year":"2006","journal-title":"J Gene Med"},{"issue":"9","key":"10.1016\/j.vaccine.2008.10.046_bib15","doi-asserted-by":"crossref","first-page":"5273","DOI":"10.4049\/jimmunol.167.9.5273","article-title":"Immunization of mice against West Nile virus with recombinant envelope protein","volume":"167","author":"Wang","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2008.10.046_bib16","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1016\/j.vaccine.2005.03.006","article-title":"A recombinant envelope protein vaccine against West Nile virus","author":"Ledizet","year":"2005","journal-title":"Vaccine"},{"issue":"15","key":"10.1016\/j.vaccine.2008.10.046_bib17","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1016\/j.vaccine.2006.08.008","article-title":"Efficacy and durability of a recombinant subunit West Nile vaccine candidate in protecting hamsters from West Nile encephalitis","volume":"25","author":"Watts","year":"2007","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2008.10.046_bib18","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.vaccine.2006.08.018","article-title":"Preparation and immunogenic properties of a recombinant West Nile subunit vaccine","volume":"25","author":"Lieberman","year":"2007","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2008.10.046_bib19","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1086\/425933","article-title":"Induction of sterilizing immunity against West Nile virus (WNV), by immunization with WNV-like particles produced in insect cells","volume":"190","author":"Qiao","year":"2004","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2008.10.046_bib20","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.4049\/jimmunol.178.5.2699","article-title":"Immunization of flavivirus West Nile recombinant envelope domain III protein induced specific immune response and protection against West Nile virus infection","volume":"178","author":"Chu","year":"2007","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2008.10.046_bib21","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.vaccine.2007.10.055","article-title":"Immunization with West Nile virus envelope domain III protects mice against lethal infection with homologous and heterologous virus","volume":"26","author":"Martina","year":"2008","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2008.10.046_bib22","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1086\/517613","article-title":"A West Nile virus recombinant protein vaccine that coactivates innate and adaptive immunity","volume":"195","author":"McDonald","year":"2007","journal-title":"J Infect Dis"},{"issue":"22","key":"10.1016\/j.vaccine.2008.10.046_bib23","doi-asserted-by":"crossref","first-page":"11000","DOI":"10.1128\/JVI.01735-06","article-title":"Crystal structure of West Nile virus envelope glycoprotein reveals viral surface epitopes","volume":"80","author":"Kanai","year":"2006","journal-title":"J Virol"},{"issue":"5448","key":"10.1016\/j.vaccine.2008.10.046_bib24","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1126\/science.286.5448.2331","article-title":"Isolation of West Nile virus from mosquitoes, crows, and a Cooper's hawk in Connecticut","volume":"286","author":"Anderson","year":"1999","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.vaccine.2008.10.046_bib25","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1086\/523654","article-title":"Antibodies targeting linear determinants of the envelope protein protect mice against West Nile virus","volume":"196","author":"Ledizet","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2008.10.046_bib26","series-title":"Arboviruses","year":"1989"},{"issue":"5","key":"10.1016\/j.vaccine.2008.10.046_bib27","doi-asserted-by":"crossref","first-page":"405","DOI":"10.4269\/ajtmh.2001.65.405","article-title":"Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3\u2032-untranslated region","volume":"65","author":"Durbin","year":"2001","journal-title":"Am J Trop Med Hyg"},{"issue":"23","key":"10.1016\/j.vaccine.2008.10.046_bib28","doi-asserted-by":"crossref","first-page":"12910","DOI":"10.1128\/JVI.78.23.12910-12918.2004","article-title":"Chimpanzee Fab fragments and a derived humanized immunoglobulin G1 antibody that efficiently cross-neutralize dengue type 1 and type 2 viruses","volume":"78","author":"Goncalvez","year":"2004","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2008.10.046_bib29","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1073\/pnas.022652799","article-title":"West Nile virus\/dengue type 4 virus chimeras that are reduced in neurovirulence and peripheral virulence without loss of immunogenicity or protective efficacy","volume":"99","author":"Pletnev","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"10.1016\/j.vaccine.2008.10.046_bib30","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.0818-9641.2004.01286.x","article-title":"Aluminium compounds for use in vaccines","volume":"82","author":"Lindblad","year":"2004","journal-title":"Immunol Cell Biol"},{"issue":"1","key":"10.1016\/j.vaccine.2008.10.046_bib31","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1128\/JCM.42.1.65-72.2004","article-title":"Detection of human anti-flavivirus antibodies with a West Nile virus recombinant antigen microsphere immunoassay","volume":"42","author":"Wong","year":"2004","journal-title":"J Clin Microbiol"},{"issue":"4","key":"10.1016\/j.vaccine.2008.10.046_bib32","doi-asserted-by":"crossref","first-page":"714","DOI":"10.3201\/eid0704.010420","article-title":"West Nile virus infection in the golden hamster (Mesocricetus auratus): a model for West Nile encephalitis","volume":"7","author":"Xiao","year":"2001","journal-title":"Emerg Infect Dis"},{"issue":"14","key":"10.1016\/j.vaccine.2008.10.046_bib33","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1001\/jama.297.14.1577","article-title":"Safety and immunogenicity of a baculovirus-expressed hemagglutinin influenza vaccine: a randomized controlled trial","volume":"297","author":"Treanor","year":"2007","journal-title":"JAMA"},{"issue":"35","key":"10.1016\/j.vaccine.2008.10.046_bib34","doi-asserted-by":"crossref","first-page":"4442","DOI":"10.1016\/j.vaccine.2005.03.042","article-title":"An evaluation of dengue type-2 inactivated, recombinant subunit, and live-attenuated vaccine candidates in the rhesus macaque model","volume":"23","author":"Putnak","year":"2005","journal-title":"Vaccine"},{"issue":"6972","key":"10.1016\/j.vaccine.2008.10.046_bib35","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nature02165","article-title":"Structure of the dengue virus envelope protein after membrane fusion","volume":"427","author":"Modis","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2008.10.046_bib36","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0065-3527(06)68006-8","article-title":"Vaccines for viral and parasitic diseases produced with baculovirus vectors","volume":"68","author":"van Oers","year":"2006","journal-title":"Adv Virus Res"},{"issue":"2","key":"10.1016\/j.vaccine.2008.10.046_bib37","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4269\/ajtmh.1991.45.159","article-title":"Dengue-1 virus envelope glycoprotein gene expressed in recombinant baculovirus elicits virus-neutralizing antibody in mice and protects them from virus challenge","volume":"45","author":"Putnak","year":"1991","journal-title":"Am J Trop Med Hyg"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2008.10.046_bib38","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/BF01309465","article-title":"Protective efficacy in mice of a secreted form of recombinant dengue-2 virus envelope protein produced in baculovirus infected insect cells","volume":"139","author":"Delenda","year":"1994","journal-title":"Arch Virol"},{"issue":"23","key":"10.1016\/j.vaccine.2008.10.046_bib39","doi-asserted-by":"crossref","first-page":"11467","DOI":"10.1128\/JVI.01125-06","article-title":"Crystal structure of the West Nile virus envelope glycoprotein","volume":"80","author":"Nybakken","year":"2006","journal-title":"J Virol"},{"issue":"5871","key":"10.1016\/j.vaccine.2008.10.046_bib40","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1126\/science.1153263","article-title":"The flavivirus precursor membrane\u2013envelope protein complex: structure and maturation","volume":"319","author":"Li","year":"2008","journal-title":"Science"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08014503?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08014503?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T02:23:36Z","timestamp":1557887016000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08014503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S0264410X08014503"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.10.046","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}